Voyager Names Steven Hyman To Board
This article was originally published in Scrip
Voyager Therapeutics, Inc., a gene therapy company focusing on the CNS, has appointed Steven Hyman to its board of directors. With over 20 years of scientific leadership experience, Hyman has been president of the Society for Neuroscience and since 2012; he has been director of the Stanley Centre for Psychiatric Research at the Broad Institute of Harvard and MIT. Previously Hyman was the director of the US National Institute of Mental Health and was also the founding president of the International Neuroethics Society.